CARDLYTICS, INC.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $36.9M | $34.3M | $66.8M | $52.0M | $58.0M | $56.4M | $74.0M | $67.1M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $5.5M | $6.4M | $10.8M | $8.8M | $9.9M | $10.3M | $9.9M | $13.2M |
| SG&A Expense | $7.9M | $8.3M | $11.2M | $10.9M | $12.2M | $12.9M | $13.8M | $12.1M |
| Operating Income | $-5.4M | $-8.3M | $-12.3M | $-68.9M | $-9.6M | $-11.1M | $-8.3M | $-148.5M |
| Operating Margin | -14.8% | -24.1% | -18.4% | -132.3% | -16.5% | -19.7% | -11.2% | -221.5% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-8.7M | $-13.8M | $-14.4M | $-72.7M | $-6.1M | $-10.3M | $-15.6M | $-145.2M |
| Income Tax Expense | $0 | $0 | — | — | $0 | $0 | — | — |
| Net Income | $-14.9M | $-4.5M | $-8.3M | $-72.7M | $-9.3M | $-13.3M | $-15.6M | $-145.2M |
| Net Margin | -40.3% | -13.1% | -12.4% | -139.7% | -16.0% | -23.5% | -21.1% | -216.5% |
| EPS (Basic) | $-1.50 | $-0.25 | $-0.15 | $-1.36 | $-0.18 | $-0.26 | $-0.36 | $-2.90 |
| EPS (Diluted) | $-1.50 | $-0.25 | $-0.15 | $-1.36 | $-0.18 | $-0.26 | $-0.36 | $-2.90 |
| Shares Outstanding (Basic) | 5.8M | 54.9M | 53.1M | 53.5M | 5.3M | 51.9M | 48.4M | 50.0M |
| Shares Outstanding (Diluted) | 5.8M | 54.9M | 53.1M | 53.5M | 5.3M | 51.9M | 48.4M | 50.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |